Fact CheckerSign in

NCT03842475Recruiting

Who Will Benefit From Bariatric Surgery for Diabetes?

Who Will Benefit From Bariatric Surgery for Diabetes? Using Fat Distribution Measurement, Gut Hormone Profiles and Genetic Data to Predict Diabetes Remission

Source: ClinicalTrials.gov · Last updated 19 Apr 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.

Status (registry)
Recruiting
Study type
Observational
Enrollment
210 (estimated)
First submitted
31 Jan 2019
Start date
1 Oct 2018
Primary completion date
1 Jan 2025
Lead sponsor
Imperial College London
NCT number
NCT03842475

What you commit to

  • Study type: Observational
  • Planned participants: 210
  • From 1 Oct 2018 to the primary completion date, 1 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 diabetes
  • Secondary diabetes or absence of β-cell function
  • Unable to undergo DEXA, cirrhosis, ascites, or other condition that may modify body fat composition e.g. underlying malignancy
  • History of any medical, or other condition, or use of any medications, including over-the-counter products, which, in the opinion of the investigators, would either interfere with the study

Lab values

  • Abnormal glucose tolerance and fasting glucose

Other

  • Current pregnancy
  • Inability to give informed consent
  • Low fasting C-peptide
  • Current smoker
  • Participation in another (interventional) trial within the last 3 months
  • Unable to understand English
    • Healthy volunteers
  • Without access at home to a telephone, or other factor likely to interfere with ability to participate reliably in the study
  • Pregnancy or breastfeeding
  • Unable to maintain adequate contraception for the duration of the study
  • Donated blood during the preceding 3 months or intention to do so before the end of the study
  • Current smoker
  • Participation in another trial within the last 3 months
  • Unable to understand English

Who the study is looking for

  • Males and females planning to undergo RYGB
  • 18-80 years
  • Type 2 diabetes mellitus or prediabetes
  • Stable weight for at least 3 months
  • Obese (BMI ≥30kg/m2)
  • Eligible for surgery on the National Health Service (NHS) under The National Institute for Health and Care Excellence (NICE) 2014 criteria
  • Aged 18-80 years
  • Male or female
  • Body mass index 19 - 25 kg/m2
  • Stable weight for at least three months

Criteria the registry did not label

  • Bariatric surgery group

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Imperial College Healthcare NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.